š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This randomized clinical trial intended to evaluate the efficacy of a techn...
Status
Completed
Location
IguaƧu University
Start Date
2021-10-04
Trial ID
NCT04942158
Botox acts on nerve endings, yet there are no nerve endings inside the musc...
Status
Unknown
Location
Automatic Subdermal Injector System, Inc
Start Date
2016-01
Trial ID
NCT02074163
Treatments Being Tested
The investigators are developing a new nuclear medicine imaging technique f...
Status
Completed
Location
University of Pittsburgh
Start Date
2011-10
Trial ID
NCT01486199
Treatments Being Tested
This study will evaluate GSK Biologicals' DTPa-HBV-IPV/Hib vaccine given as...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-09-23
Trial ID
NCT00753649
Treatments Being Tested
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
Vibrating-mesh nebulizers ensure currently the best deposition output and a...
Status
Completed
Location
Cliniques Universitaires Saint-Luc
Start Date
2015-04
Trial ID
NCT02429817
The purpose of this study was to evaluate the reactogenicity, safety and im...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-02-02
Trial ID
NCT05169905
Treatments Being Tested
This study aims to assess the effectiveness and safety of a hydrogen carbam...
Status
Completed
Location
Department of Oral Medicine & Pathology and Hospital Dentistry, School of Dentistry
Start Date
2023-05-02
Trial ID
NCT06370260
Treatments Being Tested
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
Primary Objective: ā¢ To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested